Computational drug discovery pipelines identify NAMPT as a therapeutic target in neuroendocrine prostate cancer
W Zhang, A Lee, L Lee, SM Dehm… - Clinical and …, 2024 - Wiley Online Library
Neuroendocrine prostate cancer (NEPC) is an aggressive advanced subtype of prostate
cancer that exhibits poor prognosis and broad resistance to therapies. Currently, few …
cancer that exhibits poor prognosis and broad resistance to therapies. Currently, few …
A Multi-Drug Concentration Gradient Mixing Chip: A Novel Platform for High-Throughput Drug Combination Screening
J Fu, Y Feng, Y Sun, R Yi, J Tian, W Zhao, D Sun… - Biosensors, 2024 - mdpi.com
Combinatorial drug therapy has emerged as a critically important strategy in medical
research and patient treatment and involves the use of multiple drugs in concert to achieve a …
research and patient treatment and involves the use of multiple drugs in concert to achieve a …